AI-Driven Rehabilitation ProgramTraditional Physical Therapy Program
AI-Driven Rehabilitation Program: A personalized rehabilitation program guided by artificial intelligence, including individualized exercise prescription and progression.
Traditional Physical Therapy Program: A conventional physical therapy rehabilitation program delivered according to the study protocol
Study summary
Low back dysfunction is one of the most common musculoskeletal disorders and is associated with pain, disability, and reduced quality of life. Artificial intelligence (AI) has emerged as a promising tool to support personalized rehabilitation by improving exercise prescription, monitoring adherence, and providing real-time feedback. This randomized controlled trial aims to compare the effectiveness of an AI-driven rehabilitation program with a traditional physical therapy program in patients with low back dysfunction. Primary outcomes include pain intensity, functional disability, and quality of life. The findings may provide evidence regarding the role of AI-assisted rehabilitation in improving clinical outcomes.
Eligibility
Sex
ALL
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria:
* Adults aged 18-45 years.
* Male or female participants.
* Clinical diagnosis of low back dysfunction by a physiotherapist or physician.
* Symptoms lasting more than 3 months.
* Ability to participate in physical therapy or use AI-based rehabilitation tools.
* Willingness to comply with the study protocol and provide written informed consent.
Exclusion Criteria:
* Recent spinal injury or spinal surgery.
* Previous spinal surgery within the last 6 months.
* Severe neurological disorders (e.g., multiple sclerosis or Parkinson's disease).
* Chronic conditions that significantly limit mobility (e.g., advanced arthritis).
* Current use of strong opioid analgesics.
* Severe psychiatric disorders.
* Inability to use or access the required technology for the AI intervention.
Primary outcome measure(s)
Pain Intensity — Baseline and immediately post intervention 6 weeks of treatment. Pain intensity measured using the Visual Analogue Scale (VAS), a 10-cm self-reported pain scale ranging from 0 (no pain) to 10 (worst imaginable pain).
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.